Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Charles River Laboratories International Inc. (CRL)

136.12   1.25 (0.93%) 07-15 16:02
Open: 135.17 Pre. Close: 134.87
High: 136.64 Low: 134.14
Volume: 289,200 Market Cap: 6636M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 136.958 - 137.866 137.866 - 138.686
Low: 131.877 - 133.045 133.045 - 134.1
Close: 134.323 - 136.156 136.156 - 137.812

Technical analysis

as of: 2019-07-15 4:41:11 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 161.60     One year: 168.65
Support: Support1: 128.60    Support2: 107.00
Resistance: Resistance1: 138.36    Resistance2: 144.39
Pivot: 139.02
Moving Average: MA(5): 136.98     MA(20): 138.19
MA(100): 137.84     MA(250): 129.85
MACD: MACD(12,26): 1.13     Signal(9): 1.83
Stochastic oscillator: %K(14,3): 20.33     %D(3): 30.31
RSI: RSI(14): 48.66
52-week: High: 149.07  Low: 103.00  Change(%): 15.7
Average Vol(K): 3-Month: 37160  10-Days: 28006

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CRL has closed above bottom band by 25.0%. Bollinger Bands are 14.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 10 Jun 2019 17:08:07 Z
Charles River Laboratories International Breaks Above 200-Day Moving Average - Bullish for CRL

Mon, 13 May 2019 11:09:09 Z
Investing $1,000 Into This Marijuana Stock in 2016 Would Leave You With Pennies on the Dollar Today

Tue, 07 May 2019 21:18:23 Z
Charles River Laboratories International Inc (CRL) Q1 2019 Earnings Call Transcript

Tue, 07 May 2019 14:18:27 Z
Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates

Wed, 01 May 2019 18:16:15 Z
Why Heron Therapeutics and Pacira BioSciences Are Moving in Opposite Directions Today

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 48.75
Shares Float (M) 47.99
% Held by Insiders 1.67
% Held by Institutions 95.66
Shares Short (K) 1170
Shares Short P. Month (K)

Stock Financials

EPS 4.650
EPS Est. Current Year 5.100
EPS Est. Next Year 5.610
EPS Est. Next Quarter 1.300
Forward EPS 6.571
Book Value (p.s.) 28.680
PEG Ratio 1.83
Profit Margin 9.63
Operating Margin 15.36
Return on Assets (ttm) 6.6
Return on Equity (ttm) 17.8
Qtrly Rev. Growth 22.4
Gross Profit (p.s.) 17.286
Sales Per Share
EBITDA (p.s.) 11.056
Qtrly Earnings Growth 4.80
Operating Cash Flow (M) 392.85
Levered Free Cash Flow (M) 273.94

Stock Valuations

P/E 29.27
P/E Growth Ratio 0.01
P/BV 4.75
P/S 134328944.00
P/CF 16.89

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.